John E Milad

@johnemilad.bsky.social

CEO at ERS Genomics | Reformed Venture Investor

“Rare” kidney diseases leave a deep and widespread impact. 160,000+ people in the UK are affected — driving 25% of dialysis demand and costing the NHS £263m a year. As a @kidneyresearchuk.org Trustee, I’m calling for faster diagnosis and fairer access to care. 🔗 bit.ly/47Wdp5Z #KidneyHealth

Collectively common, rare kidney disease report - Kidney Research UK

A report about the impact of rare kidney diseases in the UK including diagnosis delays and waits for new treatments.

kidneyresearchuk.org